| LTX-Credence Corporation F3Q10 (Qtr End 04/30/2010) Earnings Call Transcript LTX-Credence Corporation (LTXC)F3Q10 Earnings Call May 26, 2010 10:00 am ETComplete Story » seekingalpha.com |
YM BioSciences Reshuffles the Cytopia Deck Bio Tuesday submits: YM BioSciences (YMI) got more than it bargained for with its recent acquisition of Australia’s Cytopia. CEO David Allan told BioTuesday.ca in an exclusive interview:When we were buying the company, our sole interest was in CYT997, Cytopia’s lead vascular disrupting agent (VDA).VDAs, which can disrupt the blood flow that feed tumours, became a hot target in 2007 after Britain’s Antisoma (ATSMY.PK) licensed its VDA to Novartis (NVS) in a deal valued at a total of nearly $1 billion (US dollars). Allan recalls:Complete Story » seekingalpha.com |
MannKind / Seaside 88: Not Good News for Investors Derek Lowe submits: Readers may remember Generex (GNBT), the company that's developing a buccal insulin spray. I'm not sold on their technology or their prospects, to put it mildly. In this post I took a look at the investment outfit that did a stock transaction with the company, and found them not to my taste, either.Complete Story » seekingalpha.com |
Avanir Traders Turn to Put Selling optionMONSTER submits: By Chris McKhann Options are active in Avanir Pharmaceuticals (AVNR) for a second straight session as traders seek to capitalize on the stock's volatility.Complete Story » seekingalpha.com |
Neil L. Lerner Joins Psychemedics Corporation as Top Financial Officer [PR Newswire] - Psychemedics Corporation today announced that Neil L. Lerner has joined the company as Vice President, Controller. Â us.rd.yahoo.com |